Global Cord Blood Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2022 to a ratio of 7.04, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Global Cord Blood in Mar 31 2022 quarter, has decreased to 52 days, compared to 55 days, in the 0 quarter.

If we take a look into Healthcare sector 132 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 1306.

What is Receivable Turnover Ratio?
What is Global Cord Blood Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CO Receivables Turnover Ratio	(Mar 31 2022) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2021) IV. Quarter
Y / Y Receivable Change	35.07 %	25.23 %	35.07 %	38.26 %	1.95 %
Y / Y Revenue Change	10.8 %	-	-	-	2.6 %
Receivable Turnover Ratio (TTM)	7.04	6.67	8.87	9.35	10.88
CO's Total Ranking	# 1306	# 1306	# 0	# 1307	# 0
Accounts Receivable average collection period days	52	55	41	39	34
Seq. Receivable Change	-11.42 %	12.9 %	-59.52 %	233.69 %	-17.88 %
Seq. Revenue Change	-	-	-	-	265.08 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 13
Healthcare Sector	# 133
Overall Market	# 1306

Receivable Turnover Ratio Statistics
High	Average	Low
11.72	8.77	5.28
(Mar 31 2020)		(Mar 31 2016)

CO Company Profile • Back to CO Efficiency Comparisons • Compare CO Receivables Turnover Ratio to its Competitors

Financial Statements
Global Cord Blood's Accounts Receivable	$ 20 Millions	Visit CO's Balance sheet
Global Cord Blood's Sales TTM	$ 196 Millions	Visit CO's Income Statement
Sources of CO's Revenues		Visit CO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CO's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CO's Growth Rates	CO's Roa	CO's Inventory Turnover Ratio	CO's Dividend Comparisons
CO's Profitability Ratios	CO's Roi	CO's Asset Turnover Ratio	CO's Dividend Growth
CO's Valuation Ratios	CO's Roe	CO's Financial Strength Ratios	CO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2022	Receivable at quarter ending Mar 31 2022
Strata Critical Medical Inc	26.68	$ 101.774 Millions	$ 3.815 Millions
Precision Biosciences Inc	25.95	$ 102.497 Millions	$ 3.949 Millions
Chimerix Inc	25.12	$ 0.559 Millions	$ 0.022 Millions
Advanced Container Technologies Inc	24.81	$ 4.402 Millions	$ 0.177 Millions
Talkspace Inc	24.21	$ 143.821 Millions	$ 5.940 Millions
Ngm Biopharmaceuticals Inc	23.71	$ 77.255 Millions	$ 3.259 Millions
Qhslab Inc	22.25	$ 1.465 Millions	$ 0.066 Millions
Scorpius Holdings inc	21.03	$ 1.787 Millions	$ 0.085 Millions
Catalyst Pharmaceuticals Inc	20.44	$ 153.717 Millions	$ 7.522 Millions
Theralink Technologies Inc	20.18	$ 0.504 Millions	$ 0.025 Millions
Vtv Therapeutics Inc	19.26	$ 5.018 Millions	$ 0.261 Millions
Innovage Holding Corp	19.20	$ 697.395 Millions	$ 36.326 Millions
Cadre Holdings inc	18.37	$ 421.158 Millions	$ 22.922 Millions
Talphera Inc	18.30	$ 2.749 Millions	$ 0.150 Millions
Intellia Therapeutics Inc	18.21	$ 37.860 Millions	$ 2.079 Millions
Nutriband Inc	17.74	$ 1.467 Millions	$ 0.083 Millions
Immunogen inc	17.73	$ 92.228 Millions	$ 5.201 Millions
Ethema Health Corporation	17.37	$ 2.875 Millions	$ 0.166 Millions
Chemed Corporation	17.36	$ 2,152.820 Millions	$ 124.015 Millions
Denali Therapeutics Inc	17.26	$ 82.879 Millions	$ 4.801 Millions
23andme Holding Co	17.25	$ 271.893 Millions	$ 15.763 Millions
Janux Therapeutics Inc	16.95	$ 1.589 Millions	$ 0.094 Millions
Arbutus Biopharma Corp	16.58	$ 21.456 Millions	$ 1.294 Millions
Jrsis Health Care Corp	16.46	$ 52.684 Millions	$ 3.200 Millions
Electrocore Inc	16.38	$ 6.146 Millions	$ 0.375 Millions
Histogen Inc	16.35	$ 4.356 Millions	$ 0.266 Millions
Travere Therapeutics Inc	16.31	$ 228.570 Millions	$ 14.016 Millions
Neurometrix Inc	16.07	$ 8.400 Millions	$ 0.523 Millions
Chinook Therapeutics Inc	16.01	$ 53.971 Millions	$ 3.371 Millions
Bionexus Gene Lab Corp	15.96	$ 12.942 Millions	$ 0.811 Millions

Date modified: 2026-08-30T07:00:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.